Follow-The-Filings

ASND · Ascendis Pharma A/S

Q2 2024 13F holders among managers we track Latest ownership dossier

Ticker
ASND
Type
Equity
Class
SPONSORED ADR
Total reported value ($000, long equity)
Manager Report date Value Shares